Clinical trials: Diagnostic Ability
Alzheimer's Disease
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
This study will evaluate the performance characteristics of a novel [18F] amyloid detection ligand (18F]-AV-45) with respect to its ability to distinguish patients with clinically-diagnosed probable Alzheimer's disease from…
- Trial name
- NCT00855868
- Testing
- florbetapir F 18, [11C]-PIB
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- Avid Radiopharmaceuticals
Diagnosis of Schizophrenia Spectrum Disorders
Metacognitive and Insight Therapy for Persons With Schizophrenia (RCT MERIT)
People with schizophrenia spectrum disorders are faced with significant metacognitive impairments that include difficulties in their ability to form complex representations of the self and others.
- Trial name
- NCT03427580
- Testing
- MERIT
- Where
- Israel
- Volunteers
- 54 people
- Sponsor
- Bar-Ilan University, Israel